U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Showing 11 - 14 of 14 results

Status:
US Previously Marketed
First approved in 1985

Class (Stereo):
CHEMICAL (ACHIRAL)

Targets:


Ioxaglate Sodium Meglumine (trade name Hexabrix) is a new low osmolality ionic contrast agent, that used as a diagnostic radiopaque medium. Following intravascular injection, Ioxaglate Sodium Meglumine is rapidly transported through the circulatory s...
Status:
US Previously Marketed
First approved in 1973

Class (Stereo):
CHEMICAL (ACHIRAL)

Conditions:

Metrizoic acid is a diagnostic radiopaque that usually occurs as the sodium salt. The mechanism of action of metrizoic acid is as a X-Ray Contrast Activity.
Status:
US Previously Marketed
First approved in 1954

Class (Stereo):
CHEMICAL (ACHIRAL)



Iodipamide is used as a contrast agent for cholecystography and intravenous cholangiography. Following intravenous administration of Cholografin Meglumine, iodipamide is carried to the liver where it is rapidly secreted. The contrast medium appears i...
structurally diverse
Status:
US Approved Rx (1954)
First approved in 1954

Class:
STRUCTURALLY DIVERSE

Showing 11 - 14 of 14 results